Pharmaceutical formulations for the treatment of alzheimer's disease
US9345722B2 · kind B2 · utility
0Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2007 |
| Grant date | May 24, 2016 |
| Priority date | — |
| Expiry date | Mar 1, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relate to pharmaceutical formulations that include a CPHPC component and a delivery agent compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.